Search This Blog

Tuesday, November 6, 2018

ANI Pharmaceuticals reports Q3 adjusted EPS $1.29, consensus $1.17


Reports Q3 revenue $50.70M, consensus $50.96M.
https://thefly.com/landingPageNews.php?id=2818397
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)